HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Cholesterol Disorders


The Practical Cardiology™ Cholesterol Disorders clinical resource center offers the latest information from the field of lipidology. With hypercholesterolemia and hyperlipidemia representing a crucial aspect of risk management, this page will be a hub for information related to the latest in cholesterol management and dyslipidemia, including articles, videos, and podcasts.

Cardiology Month in Review: November 2022

November 26, 2022

The November 2022 cardiology month in review features the top content from AHA Scientific Sessions 2022, new data related to use of direct oral anticoagulation, and an FDA warning to companies over violations of the FD&C Act.

SPORT: Supplements Fail to Lower LDL-C in Primary Prevention Population

November 08, 2022

Erin Michos, MD, provides further insight in an on-site interview AHA 22 related to results of the SPORT trial, which provide direct comparative insights into the impact of several dietary supplements and placebo therapy relative to low-dose statin therapy in a primary prevention cohort.

Ocean(a)-DOSE: Olpasiran Shows Promise for Lowering Lipoprotein(a)

November 06, 2022

Results of the Ocean(a)-DOSE trial, a phase 2 dose-finding study presented at AHA 22, suggests use of olpasiran dosed at 75 mg or higher every 12 weeks was associated with a reduction of Lp(a) among 95% of patients.

Preexisting Statin Use Linked to Lower COVID-19 Severity

October 24, 2022

An analysis of electronic medical record data from more than 140k patients hospitalized at 185 medical centers in the US provides insight into associations between preexisting statin use and reduced risk of severe disease in COVID-19.

Study Details Gaps in Diagnosis for Homozygous Familial Hypercholesterolemia in the US

October 12, 2022

An analysis of the CASCADE FH Registry provides insight into differences in patient characteristics and outcomes among those with homozygous familial hypercholesterolemia enrolled in the registry as children and those enrolled in the registry as adults.

Rethinking Statins: Time for Primordial Prevention?

September 27, 2022

Statins and their specific role have been the subject of debate for years. In this feature, 6 leading experts in cardiometabolic health share their perspectives on whether statins should be used in the sense of primordial prevention for ASCVD.